[Use of Clopixol Acutard 50 and 100 mg (zuclopenthixol acetate) as a therapeutic drug in crisis at the Cery psychiatric hospital].

Abstract

After reviewing the different pharmacological treatments of psychotic states, the author presents an evaluation of the clinical effectiveness of Clopixol Acutard (zuclopenthixol acetate in a viscoleo solution): 48% of the 23 patients (14 acute psychoses and 9 acute phases in chronic psychotic patients) respond well to the treatment, and only 17% suffered from important side effects, which demonstrates the good tolerance of the medication. Clopixol Acutard convinces by its rapid effect and with a mean of 5 injections leads to sedation, which is particularly helpful in patients with paranoid symptoms. The treatment interval, i.e. an injection every 2 or 3 days, is appreciated by the patients as well as by the therapists, for it establishes a less intrusive relationship.

• Authors: D Bttig
• Journal: Schweizer Archiv fur Neurologie und Psychiatrie (Zurich, Switzerland : 1985) (Schweiz Arch Neurol Psychiatr (1985)) Vol. 139 Issue 5 Pg. 35-47 ( 1988) ISSN: 0258-7661 [Print] Switzerland
• Vernacular Title: Utilisation du Clopixol Acutard 50 et 100 mg (acétate de zuclopenthixol) comme thérapeutique de crise à l'hôpital psychiatrique de Cery.
• PMID: 2459765 (Publication Type: Journal Article)

Chemical References

• Thioxanthenes
• clopenthixol decanoate
• Clopenthixol

Topics

• Adult
• Aged
• Clopenthixol (administration & dosage, adverse effects, analogs & derivatives)
• Crisis Intervention
• Drug Administration Schedule
• Female
• Hospitals, Psychiatric
• Humans
• Male
• Middle Aged
• Psychotic Disorders (drug therapy)
• Thioxanthenes (administration & dosage)